{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Group+Regimen&page=37", "query": { "intervention": "Control Group Regimen", "page": 37 }, "page_size": 10 }, "pagination": { "page": 37, "page_size": 10, "total_count": 968, "total_pages": 97, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Group+Regimen&page=38&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Group+Regimen&page=36&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T04:25:59.613Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00826839", "title": "Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Infertility" ], "interventions": [ { "name": "Oral contraceptive pill and microdose lupron", "type": "DRUG" }, { "name": "E2 patch/antagonist", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 0, "start_date": "2009-01", "completion_date": "2012-01", "has_results": false, "last_update_posted_date": "2013-06-25", "last_synced_at": "2026-10-28T04:25:59.613Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00826839" }, { "nct_id": "NCT04494386", "title": "Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Covid19", "Corona Virus Infection", "SARS-CoV Infection", "ARDS", "Coronavirus" ], "interventions": [ { "name": "Umbilical Cord Lining Stem Cells (ULSC)", "type": "BIOLOGICAL" }, { "name": "Placebo (carrier control)", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Restem, LLC.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2020-12-23", "completion_date": "2023-05-12", "has_results": false, "last_update_posted_date": "2024-04-09", "last_synced_at": "2026-10-28T04:25:59.613Z", "location_count": 2, "location_summary": "Miami, Florida • Sioux Falls, South Dakota", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Sioux Falls", "state": "South Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04494386" }, { "nct_id": "NCT06824194", "title": "Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Immunization" ], "interventions": [ { "name": "PCV21 vaccine", "type": "BIOLOGICAL" }, { "name": "Prevnar 20 vaccine", "type": "BIOLOGICAL" }, { "name": "M-M-R II vaccine", "type": "BIOLOGICAL" }, { "name": "Rotarix", "type": "BIOLOGICAL" }, { "name": "RotaTeq", "type": "BIOLOGICAL" }, { "name": "Vaxelis vaccine", "type": "BIOLOGICAL" }, { "name": "Varivax", "type": "BIOLOGICAL" }, { "name": "Priorix", "type": "BIOLOGICAL" }, { "name": "VAQTA", "type": "BIOLOGICAL" }, { "name": "Havrix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 2360, "start_date": "2025-02-18", "completion_date": "2027-10-22", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-10-28T04:25:59.613Z", "location_count": 103, "location_summary": "Birmingham, Alabama • Guntersville, Alabama • Oneonta, Alabama + 81 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Guntersville", "state": "Alabama" }, { "city": "Oneonta", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06824194" }, { "nct_id": "NCT02743351", "title": "Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hematologic Malignancies", "Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Myelodysplastic Syndromes", "Chronic Myelogenous Leukemia", "Acute Graft-versus-host Disease" ], "interventions": [ { "name": "ProTmune", "type": "BIOLOGICAL" }, { "name": "Control Arm", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Fate Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 96, "start_date": "2016-12-20", "completion_date": "2021-11-05", "has_results": true, "last_update_posted_date": "2023-02-08", "last_synced_at": "2026-10-28T04:25:59.613Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Duarte, California • San Diego, California + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Duarte", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02743351" }, { "nct_id": "NCT01327937", "title": "A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Venous Ulcer" ], "interventions": [ { "name": "Apligraf", "type": "DEVICE" }, { "name": "Standard of Care Dressing Group", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Organogenesis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2011-03", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2015-09-24", "last_synced_at": "2026-10-28T04:25:59.613Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01327937" }, { "nct_id": "NCT06495632", "title": "Scheduled or as Needed Pain Regimen?", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pain, Postoperative" ], "interventions": [ { "name": "Motrin and narcotic", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cape Fear Valley Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 90, "start_date": "2024-08-01", "completion_date": "2027-07-31", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-28T04:25:59.613Z", "location_count": 1, "location_summary": "Fayetteville, North Carolina", "locations": [ { "city": "Fayetteville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06495632" }, { "nct_id": "NCT00899847", "title": "Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Transplantation, Homologous", "Transplantation, Autologous", "Multiple Myeloma", "Blood and Marrow Transplant (BMT)" ], "interventions": [ { "name": "Autologous peripheral blood stem cells (auto-PBSC) transplantation", "type": "PROCEDURE" }, { "name": "Allogeneic peripheral blood stem cells (allo-PBSC) transplantation", "type": "PROCEDURE" }, { "name": "Filgrastim", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Total lymphoid irradiation", "type": "RADIATION" }, { "name": "Rabbit anti-thymocyte globulin", "type": "BIOLOGICAL" }, { "name": "Mycophenolate Mofetil 250mg", "type": "DRUG" }, { "name": "Solumedrol", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Hydrocortisone", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "RADIATION", "BIOLOGICAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 9, "start_date": "2009-05", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2017-10-20", "last_synced_at": "2026-10-28T04:25:59.613Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00899847" }, { "nct_id": "NCT04976985", "title": "Osteopathic Manipulative Treatment and Migraine Headaches", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Migraine", "Migraine Disorders", "Headache Disorders", "Headache, Migraine" ], "interventions": [ { "name": "Osteopathic Manipulative Therapy (OMT)", "type": "PROCEDURE" }, { "name": "Standard of care", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "St. Luke's Hospital, Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 140, "start_date": "2018-10-02", "completion_date": "2022-03-30", "has_results": false, "last_update_posted_date": "2021-08-03", "last_synced_at": "2026-10-28T04:25:59.613Z", "location_count": 1, "location_summary": "Bethlehem, Pennsylvania", "locations": [ { "city": "Bethlehem", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04976985" }, { "nct_id": "NCT04007445", "title": "Exercise for People with Spinal Cord Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injuries" ], "interventions": [ { "name": "Formally Directed Group (Exercise Group)", "type": "BEHAVIORAL" }, { "name": "Self-Directed Group (Control Group)", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2017-04-01", "completion_date": "2020-04-29", "has_results": false, "last_update_posted_date": "2025-03-28", "last_synced_at": "2026-10-28T04:25:59.613Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04007445" }, { "nct_id": "NCT01507194", "title": "A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Postoperative Nausea and Vomiting" ], "interventions": [ { "name": "Ondansetron", "type": "DRUG" }, { "name": "Vestipitant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Accenture", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 131, "start_date": "2012-02", "completion_date": "2012-08", "has_results": false, "last_update_posted_date": "2012-10-02", "last_synced_at": "2026-10-28T04:25:59.613Z", "location_count": 7, "location_summary": "Sheffield, Alabama • Phoenix, Arizona • Boynton Beach, Florida + 3 more", "locations": [ { "city": "Sheffield", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Boynton Beach", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01507194" } ] }